Maze Therapeutics Appoints Jason Coloma as Chief Executive Officer and Expands Leadership Team
Posted by amanda punzalan under Press (No Respond)
SAN FRANCISCO, June 18, 2019 – Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Jason Coloma, Ph.D., Maze’s current chief operating officer, has been appointed as chief executive officer. He succeeds interim CEO,…